Breast-conserving therapy (BCT) for early-stage breast cancer

J Surg Oncol. 2004 Jan;85(1):14-27. doi: 10.1002/jso.20000.

Abstract

Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breast-conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention. When used appropriately, breast-conserving therapy produces maximal disease control and improves quality of life in patients with early-stage breast cancer.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery*
  • Combined Modality Therapy
  • Female
  • Humans
  • Lymph Nodes / radiation effects
  • Mastectomy, Segmental*
  • Neoplasm Staging
  • Patient Selection
  • Prognosis
  • Quality of Life
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic
  • Salvage Therapy
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal